Liquidia Corp (LQDA)
$68.10-$1.84 (-2.63%) Today
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 76 | 1,954,286 | $140.29M |
| Grant or award | 8 | 47,056 | |
| Option exercise | 48 | 440,576 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
144 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jason Adair - Officer | Option exercise | Common Stock | 9,000 | $9.31 | $84K | |
| Jason Adair - Officer | Option exercise | Common Stock | 11,799 | $9.31 | $110K | |
| Jason Adair - Officer | Option exercise | Common Stock | 10,762 | $14.20 | $153K | |
| Jason Adair - Officer | Option exercise | Common Stock | 238 | $14.20 | $3K | |
| Jason Adair - Officer | Open-market sale | Common Stock | 31,799 | $69.09 | $2.20M | |
| Jason Adair - Officer | Open-market sale | Common Stock | 41,832 | $69.09 | $2.89M | |
| Jason Adair - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 9,000 | $0.00 | - | |
| Jason Adair - Officer | Option exercise | Incentive Stock Option (right to buy) | 11,799 | $0.00 | - | |
| Jason Adair - Officer | Option exercise | Incentive Stock Option (right to buy) | 10,762 | $0.00 | - | |
| Jason Adair - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 238 | $0.00 | - | |
| Katherine Rielly-Gauvin - Director | Option exercise | Common Stock | 23,455 | $2.51 | $59K | |
| Katherine Rielly-Gauvin - Director | Option exercise | Common Stock | 13,334 | $2.59 | $35K | |
| Katherine Rielly-Gauvin - Director | Open-market sale | Common Stock | 36,789 | $74.99 | $2.76M | |
| Katherine Rielly-Gauvin - Director | Option exercise | Common Stock | 11,727 | $2.51 | $29K | |
| Katherine Rielly-Gauvin - Director | Option exercise | Common Stock | 6,666 | $2.59 | $17K | |
| Katherine Rielly-Gauvin - Director | Open-market sale | Common Stock | 18,393 | $72.23 | $1.33M | |
| Katherine Rielly-Gauvin - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 23,455 | $0.00 | - | |
| Katherine Rielly-Gauvin - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 13,334 | $0.00 | - | |
| Katherine Rielly-Gauvin - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 11,727 | $0.00 | - | |
| Katherine Rielly-Gauvin - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 6,666 | $0.00 | - | |
| Rajeev Saggar - Officer | Open-market sale | Common Stock | 29,534 | $76.84 | $2.27M | |
| Rajeev Saggar - Officer | Option exercise | Common Stock | 50,000 | $3.73 | $187K | |
| Rajeev Saggar - Officer | Open-market sale | Common Stock | 50,000 | $74.06 | $3.70M | |
| Rajeev Saggar - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Dana Boyle - Officer | Open-market sale | Common Stock | 1,600 | $87.53 | $140K | |
| Jason Adair - Officer | Open-market sale | Common Stock | 688 | $87.53 | $60K | |
 Stephen M. Bloch - Director | Open-market sale | Common Stock | 37,406 | $87.70 | $3.28M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 48,032 | $88.65 | $4.26M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 14,562 | $89.24 | $1.30M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 96,400 | $89.44 | $8.62M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 3,600 | $90.71 | $327K | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 3,596 | $79.55 | $286K | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 74,444 | $79.98 | $5.95M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 556 | $80.66 | $45K | |
| Sarah Krepp - Officer | Option exercise | Common Stock | 3,179 | - | - | |
| Sarah Krepp - Officer | Open-market sale | Common Stock | 558 | $71.39 | $40K | |
| Sarah Krepp - Officer | Open-market sale | Common Stock | 7,306 | $71.52 | $523K | |
| Sarah Krepp - Officer | Option exercise | Performance Stock Units | 3,179 | $0.00 | - | |
| Sanjeev Khindri - Officer | Open-market sale | Common Stock | 84 | $71.39 | $6K | |
| Sanjeev Khindri - Officer | Open-market sale | Common Stock | 1,101 | $71.52 | $79K | |
| Michael Kaseta - Officer | Option exercise | Common Stock | 5,829 | - | - | |
| Michael Kaseta - Officer | Option exercise | Common Stock | 7,050 | - | - | |
| Michael Kaseta - Officer | Open-market sale | Common Stock | 1,453 | $71.39 | $104K | |
| Michael Kaseta - Officer | Open-market sale | Common Stock | 18,977 | $71.52 | $1.36M | |
| Michael Kaseta - Officer | Option exercise | Performance Stock Units | 5,829 | $0.00 | - | |
| Michael Kaseta - Officer | Option exercise | Performance Stock Units | 7,050 | $0.00 | - | |
 Roger Jeffs - Officer | Option exercise | Common Stock | 13,834 | - | - | |
| Roger Jeffs - Officer | Option exercise | Common Stock | 14,333 | - | - | |
| Roger Jeffs - Officer | Open-market sale | Common Stock | 2,505 | $71.39 | $179K | |
| Roger Jeffs - Officer | Open-market sale | Common Stock | 32,744 | $71.52 | $2.34M | |
| Roger Jeffs - Officer | Option exercise | Performance Stock Units | 13,834 | $0.00 | - | |
| Roger Jeffs - Officer | Option exercise | Performance Stock Units | 14,333 | $0.00 | - | |
| Jason Adair - Officer | Option exercise | Common Stock | 3,907 | - | - | |
| Jason Adair - Officer | Option exercise | Common Stock | 2,475 | - | - | |
| Jason Adair - Officer | Option exercise | Common Stock | 3,869 | - | - | |
| Jason Adair - Officer | Open-market sale | Common Stock | 562 | $71.39 | $40K | |
| Jason Adair - Officer | Open-market sale | Common Stock | 7,301 | $71.52 | $522K | |
| Jason Adair - Officer | Option exercise | Restricted Stock Units | 3,907 | $0.00 | - | |
| Jason Adair - Officer | Option exercise | Performance Stock Units | 2,475 | $0.00 | - | |
| Jason Adair - Officer | Option exercise | Performance Stock Units | 3,869 | $0.00 | - | |
| Russell Schundler - Officer | Option exercise | Common Stock | 3,759 | - | - | |
| Russell Schundler - Officer | Option exercise | Common Stock | 6,409 | - | - | |
| Russell Schundler - Officer | Open-market sale | Common Stock | 1,046 | $71.39 | $75K | |
| Russell Schundler - Officer | Open-market sale | Common Stock | 13,692 | $71.52 | $979K | |
| Russell Schundler - Officer | Option exercise | Performance Stock Units | 3,759 | $0.00 | - | |
| Russell Schundler - Officer | Option exercise | Performance Stock Units | 6,409 | $0.00 | - | |
| Rajeev Saggar - Officer | Option exercise | Common Stock | 3,531 | - | - | |
| Rajeev Saggar - Officer | Option exercise | Common Stock | 4,487 | - | - | |
| Rajeev Saggar - Officer | Open-market sale | Common Stock | 703 | $71.39 | $50K | |
| Rajeev Saggar - Officer | Open-market sale | Common Stock | 9,223 | $71.52 | $660K | |
| Rajeev Saggar - Officer | Option exercise | Performance Stock Units | 3,531 | $0.00 | - | |
| Rajeev Saggar - Officer | Option exercise | Performance Stock Units | 4,487 | $0.00 | - | |
 Scott Moomaw - Officer | Option exercise | Common Stock | 3,108 | - | - | |
| Scott Moomaw - Officer | Option exercise | Common Stock | 4,358 | - | - | |
| Scott Moomaw - Officer | Open-market sale | Common Stock | 675 | $71.39 | $48K | |
| Scott Moomaw - Officer | Open-market sale | Common Stock | 8,864 | $71.52 | $634K | |
| Scott Moomaw - Officer | Option exercise | Performance Stock Units | 3,108 | $0.00 | - | |
| Scott Moomaw - Officer | Option exercise | Performance Stock Units | 4,358 | $0.00 | - | |
| Dana Boyle - Officer | Option exercise | Common Stock | 3,179 | - | - | |
| Dana Boyle - Officer | Open-market sale | Common Stock | 641 | $71.39 | $46K | |
| Dana Boyle - Officer | Open-market sale | Common Stock | 8,361 | $71.52 | $598K | |
| Dana Boyle - Officer | Option exercise | Performance Stock Units | 3,179 | $0.00 | - | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 25,000 | $80.18 | $2.00M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 22,718 | $80.48 | $1.83M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 27,282 | $81.31 | $2.22M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 24,147 | $79.45 | $1.92M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 853 | $80.05 | $68K | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 69,500 | $75.54 | $5.25M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 30,500 | $76.18 | $2.32M | |
| David Edward Johnson - Director | Grant or award | Common Stock, $0.001 par value per share ("Common Stock") | 5,882 | $0.00 | - | |
| Raman Singh - Director | Grant or award | Common Stock | 5,882 | $0.00 | - | |
| Stephen M. Bloch - Director | Grant or award | Common Stock | 5,882 | $0.00 | - | |
 Damian Degoa - Director | Grant or award | Common Stock | 5,882 | $0.00 | - | |
| Joanna Horobin - Director | Grant or award | Common Stock | 5,882 | $0.00 | - | |
| Arthur S. Kirsch - Director | Grant or award | Common Stock | 5,882 | $0.00 | - | |
| Katherine Rielly-Gauvin - Director | Grant or award | Common Stock | 5,882 | $0.00 | - | |
 Paul B. Manning | Grant or award | Common Stock | 5,882 | $0.00 | - | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 97,954 | $71.37 | $6.99M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 13,095 | $72.15 | $945K | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 82,740 | $71.42 | $5.91M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 2,322 | $72.08 | $167K | |
| Sarah Krepp - Officer | Open-market sale | Common Stock | 5,749 | $70.28 | $404K | |
| Sarah Krepp - Officer | Open-market sale | Common Stock | 19,131 | $70.28 | $1.34M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 14,416 | $64.48 | $930K | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 103,301 | $65.54 | $6.77M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 28,237 | $66.30 | $1.87M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 1,476 | $66.40 | $98K | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 17,369 | $67.90 | $1.18M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 25,117 | $68.91 | $1.73M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 85,285 | $69.87 | $5.96M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 20,208 | $71.07 | $1.44M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 92,128 | $71.74 | $6.61M | |
| Stephen M. Bloch - Director | Open-market sale | Common Stock | 686 | $72.41 | $50K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JASON ADAIR | Officer | 73,631 | $5.23M | View on EDGAR | |
| Katherine T. Rielly-Gauvin | Director | 55,182 | $4.10M | View on EDGAR | |
| RAJEEV SAGGAR | Officer | 50,000 | $3.70M | View on EDGAR |
Liquidia Corp (LQDA) had 36 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for LQDA runs to 144 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of LQDA were filed in the last 90 days. 1 purchase is on record for this company.
76 insider sales of LQDA were filed in the last 90 days, totaling $140.29M.
This page tracks LQDA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add LQDA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
